Abstract

Case Report

Transcatheter Aortic Valve Implantation in Two High-Risk Patients with Low Coronary Ostial Heights Using the Novel Balloon-Expandable Myval Valve

Raja Ramesh N*, Ramesh Daggubati and Ramesh Babu P

Published: 01 August, 2023 | Volume 8 - Issue 2 | Pages: 089-099

The treatment of severe aortic stenosis by transcatheter aortic valve implantation (TAVI) is challenging in patients with high-risk coronary anatomy that is predisposed to iatrogenic or delayed coronary obstruction. Hence, the evidence on performing TAVI with adequate coronary protection with or without deploying a stent needs to be accumulated. We report two cases of TAVI performed in patients with low coronary heights, wherein a “wire only” strategy was used to provide coronary protection along with the implantation of a novel balloon-expandable Myval THV. The first patient underwent a valve-in-valve TAVI, while the second patient underwent the replacement of a native bicuspid Type 1A valve. This case series presents two high-risk TAVI cases wherein a guide extension catheter and a supportive coronary guidewire provided sufficient coronary protection. None of the cases required any rescue revascularization and no incidences of a new pacemaker implantation were reported.

Read Full Article HTML DOI: 10.29328/journal.jccm.1001159 Cite this Article Read Full Article PDF

Keywords:

Balloon-expandable valves; Coronary artery obstruction; Coronary protection; Heart team; Myval; Transcatheter aortic valve implantation; Valve in valve

References

  1. Sundt TM, Jneid H. Guideline Update on Indications for Transcatheter Aortic Valve Implantation Based on the 2020 American College of Cardiology/American Heart Association Guidelines for Management of Valvular Heart Disease. JAMA Cardiol. 2021 Sep 1;6(9):1088-1089. doi: 10.1001/jamacardio.2021.2534. PMID: 34287627.
  2. Writing Committee Members; Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021 Feb 2;77(4):450-500. doi: 10.1016/j.jacc.2020.11.035. Epub 2020 Dec 17. Erratum in: J Am Coll Cardiol. 2021 Mar 9;77(9):1276. PMID: 33342587.
  3. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG; PARTNER 2 Investigators. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016 Apr 28;374(17):1609-20. doi: 10.1056/NEJMoa1514616. Epub 2016 Apr 2. PMID: 27040324.
  4. Santangelo G, Ielasi A, Pellicano M, Latib A, Tespili M, Donatelli F. An Update on New Generation Transcatheter Aortic Valves and Delivery Systems. J Clin Med. 2022 Jan 19;11(3):499. doi: 10.3390/jcm11030499. PMID: 35159952; PMCID: PMC8837046.
  5. Hsiung I, Spilias N, Bazarbashi N, Ahuja KR, Patel J, Kaur S, Rossi J, Gad M, Abdelfattah O, Saad A, Popovic Z, Miyasaka R, Yun J, Weiss A, Una S, Puri R, Reed G, Krishnaswamy A, Kapadia SR. Left main protection during transcatheter aortic valve replacement with a balloon-expandable valve. Journal of the Society for Cardiovascular Angiography & Interventions. 2022; 1(4): 100339. doi: 10.1016/j.jscai.2022.100339.
  6. Jabbour RJ, Tanaka A, Finkelstein A, Mack M, Tamburino C, Van Mieghem N, de Backer O, Testa L, Gatto P, Purita P, Rahhab Z, Veulemans V, Stundl A, Barbanti M, Nerla R, Sinning JM, Dvir D, Tarantini G, Szerlip M, Scholtz W, Scholtz S, Tchetche D, Castriota F, Butter C, Søndergaard L, Abdel-Wahab M, Sievert H, Alfieri O, Webb J, Rodés-Cabau J, Colombo A, Latib A. Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2018 Apr 10;71(14):1513-1524. doi: 10.1016/j.jacc.2018.01.066. PMID: 29622157.
  7. Nakashima M, Watanabe Y. Transcatheter Aortic Valve Implantation in Small Anatomy: Patient Selection and Technical Challenges. Interv Cardiol. 2018 May;13(2):66-68. doi: 10.15420/icr.2017:28:1. PMID: 29928310; PMCID: PMC5980651.
  8. Khan JM, Babaliaros VC, Greenbaum AB, Spies C, Daniels D, Depta JP, Oldemeyer JB, Whisenant B, McCabe JM, Muhammad KI, George I, Mahoney P, Lanz J, Laham RJ, Shah PB, Chhatriwalla A, Yazdani S, Hanzel G, Pershad A, Leonardi RA, Khalil R, Tang GHL, Herrmann HC, Agarwal S, Fail PS, Zhang M, Pop A, Lisko J, Perdoncin E, Koch RL, Ben-Dor I, Satler LF, Zhang C, Cohen JE, Lederman RJ, Waksman R, Rogers T. Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement: Results From the Multicenter International BASILICA Registry. JACC Cardiovasc Interv. 2021 May 10;14(9):941-948. doi: 10.1016/j.jcin.2021.02.035. Epub 2021 Mar 6. PMID: 33958168; PMCID: PMC8142224.
  9. Conzelmann LO, Würth A, Schymik G, Schröfel H, Anusic T, Temme S, Tzamalis P, Gerhardus J, Mukherjee C, Gonska BD, Schmitt C, Mehlhorn U. Feasibility of transcatheter aortic valve implantation in patients with coronary heights ≤7 mm: insights from the transcatheter aortic valve implantation Karlsruhe (TAVIK) registry. Eur J Cardiothorac Surg. 2018 Oct 1;54(4):752-761. doi: 10.1093/ejcts/ezy130. PMID: 29617804.
  10. Yamamoto M, Shimura T, Kano S, Kagase A, Kodama A, Koyama Y, Watanabe Y, Tada N, Takagi K, Araki M, Shirai S, Hayashida K. Impact of preparatory coronary protection in patients at high anatomical risk of acute coronary obstruction during transcatheter aortic valve implantation. Int J Cardiol. 2016 Aug 15;217:58-63. doi: 10.1016/j.ijcard.2016.04.185. Epub 2016 May 4. PMID: 27179209.
  11. Palmerini T, Chakravarty T, Saia F, Bruno AG, Bacchi-Reggiani ML, Marrozzini C, Patel C, Patel V, Testa L, Bedogni F, Ancona M, Montorfano M, Chieffo A, Olivares P, Bartorelli AL, Buscaglia A, Porto I, Nickenig G, Grube E, Sinning JM, De Carlo M, Petronio AS, Barbanti M, Tamburino C, Iadanza A, Burzotta F, Trani C, Fraccaro C, Tarantini G, Aranzulla TC, De Benedictis M, Pagnotta P, Stefanini GG, Miura M, Taramasso M, Kang JH, Kim HS, Codner P, Kornowski R, Pelliccia F, Vignali L, Taglieri N, Ghetti G, Leone A, Galiè N, Makkar R. Coronary Protection to Prevent Coronary Obstruction During TAVR: A Multicenter International Registry. JACC Cardiovasc Interv. 2020 Mar 23;13(6):739-747. doi: 10.1016/j.jcin.2019.11.024. Epub 2020 Feb 12. PMID: 32061608.
  12. Lederman RJ, Babaliaros VC, Rogers T, Khan JM, Kamioka N, Dvir D, Greenbaum AB. Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement: From Computed Tomography to BASILICA. JACC Cardiovasc Interv. 2019 Jul 8;12(13):1197-1216. doi: 10.1016/j.jcin.2019.04.052. PMID: 31272666; PMCID: PMC6724191.
  13. Carroll JD. The Splitting of Leaflets to Prevent Coronary Occlusion During TAVR. JACC Cardiovasc Interv. 2019 Jul 8;12(13):1253-1255. doi: 10.1016/j.jcin.2019.04.009. Epub 2019 Jun 12. PMID: 31202952.
  14. Khan JM, Greenbaum AB, Babaliaros VC, Rogers T, Eng MH, Paone G, Leshnower BG, Reisman M, Satler L, Waksman R, Chen MY, Stine AM, Tian X, Dvir D, Lederman RJ. The BASILICA Trial: Prospective Multicenter Investigation of Intentional Leaflet Laceration to Prevent TAVR Coronary Obstruction. JACC Cardiovasc Interv. 2019 Jul 8;12(13):1240-1252. doi: 10.1016/j.jcin.2019.03.035. Epub 2019 Jun 12. PMID: 31202947; PMCID: PMC6669893.
  15. de Toledo JFB, Teixeirense PT, Guimaraes W, Motta J, Joaquim MR, Odone V, Mantovani J, Alves R, Gubolino LA. In-Series Transcatheter Aortic Valve Replacement-in-Transcatheter Aortic Valve Replacement: ACURATE neo-Transcatheter Heart Valve Degeneration Successfully Managed with Myval, Avoiding Coronary Flow Obstruction—A Case Report. Structural Heart. 2023. doi:10.1016/j.shj.2023.100181
  16. García-Gómez M, Delgado-Arana JR, Halim J, De Marco F, Trani C, Martin P, Won-Keun K, Montorfano M, den Heijer P, Bedogni F, Sardella G, IJsselmuiden AJJ, Campante Teles R, Aristizabal-Duque CH, Gordillo X, Santos-Martinez S, Barrero A, Gómez-Salvador I, Ancona M, Redondo A, Román JAS, Amat-Santos IJ. Next-generation balloon-expandable Myval transcatheter heart valve in low-risk aortic stenosis patients. Catheter Cardiovasc Interv. 2022 Feb;99(3):889-895. doi: 10.1002/ccd.29923. Epub 2021 Aug 14. PMID: 34390296.
  17. Delgado-Arana JR, Gordillo-Monge MX, Halim J, De Marco F, Trani C, Martin P, Infusino F, Ancona M, den Heijer P, Bedogni F, Nombela Franco L, Moreno R, Sargella G, Montorfano M, Aristizabal-Duque C, Romero-Delgado T, Santos S, Barrero A, Gomez Salvador I, IJsselmuiden S, Redondo Diéguez A, San Román Calvar JA, Amat-Santos IJ. Early clinical and haemodynamic matched comparison of balloon-expandable valves. Heart. 2022 May;108(9):725-732. doi: 10.1136/heartjnl-2021-319349. Epub 2021 Jul 20. PMID: 34285104.
  18. Abdelshafy M, Soliman O, Kim W, Ruck A, Elkoumy A, Elzomor H, Wang R, Tao L, Garg S, Mylotte D, Onuma Y, Serruys P. Quantitative angiographic assessment of aortic regurgitation posts 11 different types of TAVI devices a multicentre pooled analysis of 2665 valves. European Heart Journal. 2022; 43(2): ehac544-2078. doi: 10.1016/j.jscai.2022.100037
  19. Casenghi M, Oliva OA, Squillace M, Bellamoli M, Poletti E, Popolo Rubbio A, Testa L, Bedogni F, De Marco F. Bailout From Sinus Jailing: In-Series TAVR-in-TAVR to Avoid Coronary Flow Obstruction. JACC Case Rep. 2021 Apr 21;3(4):678-681. doi: 10.1016/j.jaccas.2021.02.022. PMID: 34317602; PMCID: PMC8302790.
  20. Ribeiro HB, Rodés-Cabau J, Blanke P, Leipsic J, Kwan Park J, Bapat V, Makkar R, Simonato M, Barbanti M, Schofer J, Bleiziffer S, Latib A, Hildick-Smith D, Presbitero P, Windecker S, Napodano M, Cerillo AG, Abdel-Wahab M, Tchetche D, Fiorina C, Sinning JM, Cohen MG, Guerrero ME, Whisenant B, Nietlispach F, Palma JH, Nombela-Franco L, de Weger A, Kass M, Sandoli de Brito F Jr, Lemos PA, Kornowski R, Webb J, Dvir D. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J. 2018 Feb 21;39(8):687-695. doi: 10.1093/eurheartj/ehx455. PMID: 29020413.
  21. Allende R, Barbosa Ribeiro H, Paradis JM, Doyle D, Pasian S, Rodés-Cabau J. Guidewire protection for a valve-in-valve transcatheter aortic valve implantation procedure with high-risk for coronary obstruction. Arch Cardiol Mex. 2014 Oct-Dec;84(4):322-4. doi: 10.1016/j.acmx.2014.04.005. Epub 2014 Sep 4. PMID: 25200591.
  22. Akinseye OA, Jha SK, Ibebuogu UN. Clinical outcomes of coronary occlusion following transcatheter aortic valve replacement: A systematic review. Cardiovasc Revasc Med. 2018 Mar;19(2):229-236. doi: 10.1016/j.carrev.2017.09.006. Epub 2017 Sep 12. PMID: 29102344.
  23. De Backer O, Søndergaard L. Is BASILICA the Standard for Preventing Coronary Obstruction in High-Risk Transcatheter Aortic Valve Replacement? JACC Cardiovasc Interv. 2021 May 10;14(9):949-951. doi: 10.1016/j.jcin.2021.03.028. PMID: 33958169.
  24. Ali N, Alnasser S, Latter D, Peterson MD, Fam NP. Double chimney stenting and triple kissing balloon inflation to prevent coronary obstruction during valve-in-valve TAVI with balloon valve fracture. EuroIntervention. 2022 Jul 22;18(4):e349-e350. doi: 10.4244/EIJ-D-22-00092. PMID: 35499840; PMCID: PMC9912954.

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Figure 1

Figure 5

Figure 1

Figure 6

Figure 1

Figure 7

Figure 1

Figure 8

Figure 1

Figure 9

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?